Histopathological regression after taxane based neoadjuvant chemotherapy in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma

類似資料

• PD-015 The prognostic role of tumour regression grade after neoadjuvant chemotherapy in patients with resectable gastro-oesophageal adenocarcinoma
  著者:: Tin, A., 等
  出版事項: (2016)
• Total neoadjuvant chemotherapy with FLOT scheme in resectable adenocarcinoma of the gastro-oesophageal junction or gastric adenocarcinoma: impact on pathological complete response and safety
  著者:: Villanueva, Luis, 等
  出版事項: (2021)
• Caspase-cleaved cytokeratin-18 and tumour regression in gastro-oesophageal adenocarcinomas treated with neoadjuvant chemotherapy
  著者:: Fareed, Khaleel R, 等
  出版事項: (2012)
• Significance of tumour regression in lymph node metastases of gastric and gastro‐oesophageal junction adenocarcinomas
  著者:: Reim, Daniel, 等
  出版事項: (2020)
• The impact of neoadjuvant chemotherapy on cardiopulmonary physical fitness in gastro-oesophageal adenocarcinoma
  著者:: Sinclair, RCF, 等
  出版事項: (2016)